Golden Helix Foundation

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Cathelijne H. van der Wouden, Anne Cambon‐Thomsen, Erika Cecchin et al. · Clinical Pharmacology & Therapeutics · 2016 · 288 citations · Full text

Relevant Pgx-markers, Genetic Epidemiology, Ubiquitous Pharmacogenomics +22

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Clint Mizzi, Eleni Dalabira, Judit Kumuthini et al. · PLoS ONE · 2016 · 153 citations · Full text

Genetic Epidemiology, Genome-wide Association Study, Biomarker (Medicine) +18

Personalized Pharmacogenomics Profiling Using Whole-Genome Sequencing

Clint Mizzi, Brock A. Peters, Christina Mitropoulou et al. · Pharmacogenomics · 2014 · 99 citations

Targeted Metabolomic Analysis of Serum Fatty Acids for the Prediction of Autoimmune Diseases

Dimitris Tsoukalas, Vassileios Fragoulakis, Evangelia Sarandi et al. · Frontiers in Molecular Biosciences · 2019 · 93 citations · Full text